Publications by authors named "Angelo Genua"

Claim this Profile
R
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.
Massimo Breccia, Antonella Russo Rossi, Valentina Giai, Bruno Martino, Carmen Fava, Angelo Genua

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targetable Mutations in V600E-Negative Hairy-Cell Leukemia.
Alessia Santi, Alessandra Venanzi, Alessandra Pucciarini, Gianluca Schiavoni, Marta Naccari, Angelo Genua

N Engl J Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Luca Lanino, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Angelo Genua

Am J Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinous and hemorrhagic pericarditis with cardiac tamponade due to acute myeloid leukemia.
Magda Zanelli, Maurizio Zizzo, Francesca Sanguedolce, Maria Elena Laurenti, Angelo Genua

Pathologica· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B19 Infection in a Patient with Common Variable Immunodeficiency.
Magda Zanelli, Loredana Ruggeri, Francesca Sanguedolce, Maurizio Zizzo, Giovanni Martino, Angelo Genua

Mediterr J Hematol Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of the thymus in myotonic dystrophy type 1.
Andrea Mignarri, Francesco Gentili, Francesco Masia, Angelo Genua, Silvia Cenciarelli

Neurol Sci· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, Massimo Federico, Emanuele Angelucci, Angelo Genua

Haematologica· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis